{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:15:22Z","timestamp":1792556122440,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.radonc.2024.110390","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:31:04Z","timestamp":1718623864000},"page":"110390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial"],"prefix":"10.1016","volume":"199","author":[{"given":"Yu-Chun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2158-7392","authenticated-orcid":false,"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Zi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110390_b0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.radonc.2024.110390_b0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-8140(89)90165-5","article-title":"Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer","volume":"14","author":"Sarrazin","year":"1989","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiation Research"},{"key":"10.1016\/j.radonc.2024.110390_b0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cllc.2018.11.013","article-title":"Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer","volume":"20","author":"Suzuki","year":"2019","journal-title":"Clinical Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110390_b0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","article-title":"Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors","volume":"13","author":"Grossman","year":"2015","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1016\/j.radonc.2024.110390_b0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","article-title":"Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy","volume":"99","author":"Davuluri","year":"2017","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110390_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-019-1287-z","article-title":"Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC","volume":"14","author":"Zhao","year":"2019","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13014-020-01494-7","article-title":"Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count","volume":"15","author":"Xie","year":"2020","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10147-020-01623-y","article-title":"Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study","volume":"25","author":"Taguchi","year":"2020","journal-title":"International Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.breast.2011.11.002","article-title":"Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy","volume":"21","author":"Vicente Conesa","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2024.110390_b0055","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-17-1323","article-title":"Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer","volume":"24","author":"Afghahi","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.radonc.2024.110390_b0060","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China","volume":"38","author":"Wang","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2532740","article-title":"Maximally Selected Rank Statistics","volume":"48","author":"Lausen","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.radonc.2024.110390_b0070","article-title":"Classical and Modern Regression with Applications (Second Edition)","volume":"83","author":"Myers","year":"1990","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.radonc.2024.110390_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","article-title":"Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy","volume":"108","author":"Sun","year":"2020","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110390_b0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2021.02.029","article-title":"Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival","volume":"158","author":"Terrones-Campos","year":"2021","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0085","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110390_b0090","article-title":"Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.radonc.2024.110390_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0100","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.prro.2019.07.010","article-title":"Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram","volume":"10","author":"van Rossum","year":"2020","journal-title":"Practical Radiation Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0105","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4143\/crt.2020.1053","article-title":"Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort","volume":"53","author":"Byun","year":"2021","journal-title":"Cancer Research and Treatment"},{"key":"10.1016\/j.radonc.2024.110390_b0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2020.07.026","article-title":"Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer","volume":"151","author":"Lee","year":"2020","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(197601)37:1<164::AID-CNCR2820370123>3.0.CO;2-H","article-title":"The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma","volume":"37","author":"Papatestas","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110390_b0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/bjc.1987.15","article-title":"Lymphocytopenia as an independent predictor of early recurrence in breast cancer","volume":"55","author":"Pattison","year":"1987","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.radonc.2024.110390_b0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","article-title":"Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma","volume":"195","author":"Byun","year":"2019","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2024.110390_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11206091","article-title":"Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy","volume":"11","author":"Mart\u00edn-Carnicero","year":"2022","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.radonc.2024.110390_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071896","article-title":"Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer","volume":"12","author":"Yoon","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2024.110390_b0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10549-022-06601-8","article-title":"RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis","volume":"193","author":"Kim","year":"2022","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/j.radonc.2024.110390_b0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00262-002-0342-y","article-title":"Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95\/Fas and CD31 expressing T-cells, in breast cancer patients","volume":"52","author":"Koukourakis","year":"2003","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/j.radonc.2024.110390_b0150","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.ijrobp.2020.12.004","article-title":"Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model","volume":"109","author":"Byun","year":"2021","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110390_b0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1200\/JCO.2014.57.3329","article-title":"Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer","volume":"33","author":"Conlon","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0165","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41416-023-02218-w","article-title":"The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer","volume":"128","author":"Sun","year":"2023","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.radonc.2024.110390_b0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.radonc.2024.110390_b0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2024.110390_b0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2019.11.014","article-title":"A framework for modeling radiation induced lymphopenia in radiotherapy","volume":"144","author":"Jin","year":"2020","journal-title":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.radonc.2024.110390_b0185","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s12094-018-1851-2","article-title":"Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients","volume":"20","author":"Yuan","year":"2018","journal-title":"Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the Cancer Institute of Mexico"},{"key":"10.1016\/j.radonc.2024.110390_b0190","doi-asserted-by":"crossref","first-page":"9691067","DOI":"10.1155\/2019\/9691067","article-title":"Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival","volume":"2019","author":"Zhang","year":"2019","journal-title":"Canadian Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.radonc.2024.110390_b0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1097-0142(197801)41:1<108::AID-CNCR2820410116>3.0.CO;2-Z","article-title":"Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation","volume":"41","author":"MacLennan","year":"1978","journal-title":"Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:33:44Z","timestamp":1725438824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024006601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"alternative-id":["S0167814024006601"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110390","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110390"}}